Borvo Clinic Kft.

Debrecen 4025

1 studies enrolling now · 3 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Dyslipidemia, Obesity, Overweight, Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight, Type2 Diabetes

Studies at this site

• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
• Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight — Running, not enrolling
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early